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Recognizing Type VII Collagen 
Type VII collagen, a protein of epithelial basement mem~ranes, is 
mposed of a trimer of identical a chains. Each polypeptide has a ~~5-kDa noncollagenous amino-terminal domain and a 145-kDa 
collagenous carboxy-terminal section. In the December 1992 issue 
f this journal, Gammon et al (] Invest Dermatol 99:691-696, ~ 992) reported the isolation and characterization of a cDNA encod-
. g the N-terminal noncollagenous (NC1) portion of type VII col-;~gen. Autoantibodies in serum from a patient with epidermolys!s 
bullosa supplied a handl~ for the ~DNA library screen1l1g stef. TIllS 
lone provided further 1I1formatlon about the structural 'regIOns of ~pe VII collagen. T!le NCI domain contains m~ltiple ta~dem re-
eats of fibronectin-hke sequences as well as a regIOn that b1l1ds type fv collagen and a segment that has homology with von Willebra~d 
factor A. Both epidermolysis bullosa acquisita (EBA) and systemiC 
lupus erythematosus (SLE) are autoimmune blistering disorders. 
Each is characterized by tissue-bound and circulating IgG autoanti-
bodies that react with collagen in the epithelial basement mem-
brane. In this issue Gammon and his colleagues (p. 618) create an 
epitope map of the NCI domain of type VII collagen and determine 
the sites where EBA and SLE autoantibodies interact with the pro-
tein. 
A panel of overlapping cDNA fragments that span the protein 
coding region was subcloned into two different expression vectors. 
Each new clone produced a fusion protein containing one or more 
identified structural elements in N Cl. By Western immunoblot and 
enzyme-linked immunosorbent assays, seven EBA and five SLE pa-
tient sera targeted each fusion protein for autoantibody recognition. 
Because type VII collagen plays a role in lamina densa-dermal 
adhesion, and because alteration of the C017 A-I gene in dystrophic 
forms of EB disrupts formation of anchoring fibrils, the authors 
reasoned that autoantibodies of EBA and SLE might interfere with 
adherence by interacting with different epitopes of type VII colla-
gen. The authors make several interesting points. First, all but one 
(> 90%) of the sera containing type VII collagen antibodies react 
with fusion proteins generated from the NCI domain. Second, most 
sera. recognized at least two regions in the fibronectin-like repeat 
sectIOn. These areas do not share common amino acid sequences and 
are. not cross-reactive, indicating that they are distinct epitopes. 
Third, no antisera reacted unambiguously with the putative colla-
gen binding domain. 
The finding of similar epitope recognition by EBA and SLE au-
toantibodies suggests that differences in the clinical phenotypes of 
these disorders do not result from differences in the sites of the 
colla.gen VII molecule recogniz.ed by the antibodies, and supports 
preViOUS work by the group 1U?ICa~lI1g that functional heterogene-
Ity among collagen VII autoantibodies may influence clinical pheno-
typ~ (J Invest Dermatol 89:478-483, 1987) . The possibility re-
maills ~hat there are fi?e d~fferences in precise peptide sequences 
recogl1lze.d by these ant~b?dles and the group is currently addressing 
thiS question by determmmg which amino acid sequences are recog-
nized by the autoantibodies. 
Another Warning About Alcohol Consumption 
Severe psoriasis has been effectively treated with the aromatic reti-
noid acetretin and its ester, etretinate. The ester is more active and 
more easily absorbed than acetretin; however, it accumulates in 
adipose tissues after chronic administration. Because both com-
pounds are potentially teratogenic, acetretin has been favored for 
treatment of women during their childbearing years because it is 
more rapidly eliminated from the body. Recently, the 2-month 
anticonceptive period following acetretin therapy was extended to 2 
years aft~r some pati~nts showed elevated plasma levels of etretin-
ate. P.rehmmary studies in rats showed that ethanol might act as a 
contnbutll1g factor in the esterification of acetretin in vivo. To clar-
i~y the relationship between plasma levels of these retinoid metabo-
htes. a?d alcohol use, Larsen et al (p. 623) monitored 10 patients 
recelvll1g a 3-month chronic acetretin treatment for psoriasis. Blood 
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levels of retinoids were sampled during administration and at inter-
vals after the course of therapy. The correlation was striking: the 
higher the alcohol consumption of the patient, the greater the 
plasma concentration of etretinate. None of the individuals had 
previously had retinoids. 
Until recently the biologic hydrolysis of etretinate to acetretin 
was assumed to be irreversible and to be followed directly by de-
methylation and biliary elimination or renal excretion. This study 
points out that although a low level of enzymatic esterification 
occurs normally, the conversion is enhanced by the presence of 
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alcohol. Because etretinate collects in fatty tissues, the effect of 
alcohol is to prolong the presence of more highly teratogenic reti-
noids in the body. Although research continues on the metabolism 
of these compounds, the clinical significance of this work is to stress 
the need for direct monitoring of plasma retinoid levels after acetre-
tin treatment in women of childbearing age. It also reminds us that 
drug metabolism is important and that standard dietary habits of 
laboratory animals may not always predict human influences on 
drug therapy. 
Growth Factors and Keratinocyte Locomotion 
Many cell types within the skin produce and respond to growth 
factors, such as transforming growth factor (TGFa), epidermal 
growth factor (EGF), insulin, and insulin-like growth factor (IGF-
I) . These molecules exert their effects by binding to and activating 
cell surface receptors. Effects ofTGFa and EGF are mediated by the 
EGF receptor; insulin and IGF-I bind the insulin receptor. These 
molecules often alter the rate of proliferation or motility of cultured 
skin cells, and they have been shown to accelerate wound healing. 
Under extreme conditions, keratinocytes in psoriatic lesions over-
produce TGFa, and psoriasis-like changes develop in transgenic 
mice cartying the human TGFa gene. Two papers in this issue 
examine the role of growth factors in promoting migration ofkerati-
nocytes in culture. Both use a "phagokinetic" assay that allows 
observation of the displacement of colloidal gold particles plated 
onto a subcellular matrix . 
Ju et al (p. 628) examined the synthesis and processing ofTGFa 
in human keratinocytes transfected with a retroviral vector carrying 
the full-length human eDNA sequence. Metabolic labeling and 
immunoprecipitation experiments define at least five forms of 
TGFa including the mature "secreted" TGFa, which can poten-
tially interact with the EGF receptor. Cells that produce TGFa as 
well as normal keratinocyte cultures to which TGFa has been added 
show a marked enhancement of motility. These investigators also 
show that high concentrations of bovine pituitary extract interact 
synergistically with TGFa to stimulate keratinocyte locomotion. 
This assay system will be useful for further studies dissecting the 
regulation ofTGFa production by keratinocytes . It also should aid 
in analysis of the forms ofTGFa that stimulate locomotion in these 
cells. Ando and Jensen (p . 633) show that, as with TGFa, addition 
ofEGF to culture medium enhances the motility ofkeratinocytes in 
a concentration-dependent fashion. Insulin and IGF-I also promote 
migration when the cells are plated over a collagen or fibronectin 
matrix . Receptor affinity for different molecules plays a role in the 
way growth factors stimulate cells. A monoclonal antibody that 
bound the EGF receptor blocked the stimulation by EGF but had no 
effect on the response to insulin or IGF-I. Similarly, the difference 
in concentration of insulin and IGF-I required for stimulation of 
motility reflect the different affinities of insulin and IGF-I for the 
insulin receptor. Taken together, these two studies emphasize the 
complexity of the growth-stimulatory pathways within keratino-
cytes. They also provide a direction for analysis and a starting point 
for the interface of ill vitro and ill vivo studies ofkeratinocyte growth 
factors in wound healing and embryogenesis. 
A Sensitive Assay for Borrelia burgdotjeri 
Morphea and lichen sclerosus et atrophicus (LSA) share several his-
topathologic characteristics. Both exhibit early cellular inflamma-
tory processes and late sclerosis or atrophy in collagen and elastic 
fibers. There is evidence that these conditions are caused by B. 
burgdorfj, the spirochete that causes Lyme disease; however, isola-
tion orthe spirochetes is difficult and serology is often inconclusive. 
Recently, polymerase chain reaction has been used as a sensitive tool 
for the detection of spirochetes in skin samples from patients with 
Lyme borreliosis. Two-phase amplification with nested primer 
pairs resulted in production of a characteristic 290- base pair DNA 
fragment encoding a portion of the spirochete flagellar protein. 
Schempp and his co-workers (p. 717) demonstrated that biopsies 
from patients with morphea and LSA were all positive for the pres-
ence of B. burgdorji DNA, despite negative serology reports. Normal 
skin and biopsies from subjects with other inflammatory dermatoses 
served as controls and were negative. Although follow up and ef-
fects of antibiotic treatment were not described, the study provides 
important groundwork. The patients were all from Europe, and it is 
not known whether the results apply elsewhere. This report em-
phasizes the sensitivity of polymerase chain reaction as a diagnostic 
approach for infectious agents that are difficult to detect by other 
means, or when the mechanism of pathogenesis is unclear. Lastly, 
use of paraffin-embedded material for this type of assay facilitates 
sample handling and allows retrospective studies on archival mate-
rial. 
